From Care to Cure
Home
About
About AMT
Management
Board of Directors
Careers
Gene Therapy
Gene Therapy
Disease Areas
Gene Therapy Worldwide
R&D
Pipeline
Platform
Programs
Collaborations
Scientific Publications
Scientific Meetings
Products
Products
Glybera
Investors
Shareholder Information
Financial Reports
Stock Information
Event Calendar
Corporate Governance
News
Latest Press Releases
Archived Press Releases
Media Kit
search
Press
Jörn Aldag
Chief Executive Officer
Tel +31 (0) 20 566 7394
j.aldag@amtbiopharma.com
